Imhoff A, Sweeney N, Bongard R, Syrlybaeva R, Gupta A, Del Carpio E
Front Chem Biol. 2025; 3.
PMID: 39749114
PMC: 11694514.
DOI: 10.3389/fchbi.2024.1385560.
Gao P, Xiao J, Guo W, Fan R, Zhang Y, Nan T
Front Genet. 2024; 15:1442277.
PMID: 39130754
PMC: 11310058.
DOI: 10.3389/fgene.2024.1442277.
Zhang Y, Cui M, Ke R, Chen Y, Xie K
aBIOTECH. 2024; 5(2):219-224.
PMID: 38974866
PMC: 11224195.
DOI: 10.1007/s42994-024-00165-5.
Morea V, Angelucci F, Bellelli A
FEBS Open Bio. 2024; 14(7):1040-1056.
PMID: 38783588
PMC: 11216940.
DOI: 10.1002/2211-5463.13794.
Elkhadragy L, Myers A, Long W
Cancers (Basel). 2024; 16(7).
PMID: 38611058
PMC: 11011113.
DOI: 10.3390/cancers16071381.
Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2.
Anderson J, Vaisar D, Jones D, Pegram L, Vigers G, Chen H
Elife. 2024; 12.
PMID: 38537148
PMC: 10972564.
DOI: 10.7554/eLife.91507.
Toward physics-based precision medicine: Exploiting protein dynamics to design new therapeutics and interpret variants.
Meller A, Kelly D, Smith L, Bowman G
Protein Sci. 2024; 33(3):e4902.
PMID: 38358129
PMC: 10868452.
DOI: 10.1002/pro.4902.
Synergistic anticancer effect by targeting CDK2 and EGFR-ERK signaling.
Wu J, Chen Y, Li R, Guan Y, Chen M, Yin H
J Cell Biol. 2023; 223(1).
PMID: 37955924
PMC: 10641568.
DOI: 10.1083/jcb.202203005.
Navigating the ERK1/2 MAPK Cascade.
Martin-Vega A, Cobb M
Biomolecules. 2023; 13(10).
PMID: 37892237
PMC: 10605237.
DOI: 10.3390/biom13101555.
Probing conformational dynamics to understand kinase inhibition.
Outhwaite I, Seeliger M
Elife. 2023; 12.
PMID: 37850630
PMC: 10584368.
DOI: 10.7554/eLife.92753.
Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.
Kahsai A, Shah K, Shim P, Lee M, Shreiber B, Schwalb A
Proc Natl Acad Sci U S A. 2023; 120(43):e2303794120.
PMID: 37844230
PMC: 10614829.
DOI: 10.1073/pnas.2303794120.
Activation Loop Plasticity and Active Site Coupling in the MAP Kinase, ERK2.
Pegram L, Riccardi D, Ahn N
J Mol Biol. 2023; 435(23):168309.
PMID: 37806554
PMC: 10676806.
DOI: 10.1016/j.jmb.2023.168309.
Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2.
Anderson J, Vaisar D, Jones D, Pegram L, Vigers G, Chen H
bioRxiv. 2023; .
PMID: 37745518
PMC: 10515847.
DOI: 10.1101/2023.09.12.557258.
Hydrogen peroxide-dependent oxidation of ERK2 within its D-recruitment site alters its substrate selection.
Postiglione A, Adams L, Ekhator E, Odelade A, Patwardhan S, Chaudhari M
iScience. 2023; 26(10):107817.
PMID: 37744034
PMC: 10514464.
DOI: 10.1016/j.isci.2023.107817.
N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2.
Busca R, Onesto C, Egensperger M, Pouyssegur J, Pages G, Lenormand P
Nucleic Acids Res. 2023; 51(15):7714-7735.
PMID: 37414542
PMC: 10450180.
DOI: 10.1093/nar/gkad528.
Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods.
Shi M, Zhou Y, Wei H, Zhang X, Du M, Zhou Y
Front Pharmacol. 2023; 14:1116098.
PMID: 37124223
PMC: 10133576.
DOI: 10.3389/fphar.2023.1116098.
Evolutionary analysis of p38 stress-activated kinases in unicellular relatives of animals suggests an ancestral function in osmotic stress.
Shabardina V, Charria P, Saborido G, Diaz-Mora E, Cuenda A, Ruiz-Trillo I
Open Biol. 2023; 13(1):220314.
PMID: 36651171
PMC: 9846432.
DOI: 10.1098/rsob.220314.
The molecular genetics of RASopathies: An update on novel disease genes and new disorders.
Tartaglia M, Aoki Y, Gelb B
Am J Med Genet C Semin Med Genet. 2022; 190(4):425-439.
PMID: 36394128
PMC: 10100036.
DOI: 10.1002/ajmg.c.32012.
Contributions of extracellular-signal regulated kinase 1/2 activity to the memory trace.
Ojea Ramos S, Feld M, Fustinana M
Front Mol Neurosci. 2022; 15:988790.
PMID: 36277495
PMC: 9580372.
DOI: 10.3389/fnmol.2022.988790.
Divergent kinase WNG1 is regulated by phosphorylation of an atypical activation sub-domain.
Dewangan P, Beraki T, Paiz E, Appiah Mensah D, Chen Z, Reese M
Biochem J. 2022; 479(17):1877-1889.
PMID: 35938919
PMC: 9555795.
DOI: 10.1042/BCJ20220076.